AZ adds another two drug targets through AI discovery
AZ and its partner BenevolentAI discovered two drug targets for chronic kidney disease and idiopathic pulmonary fibrosis.
AZ and its partner BenevolentAI discovered two drug targets for chronic kidney disease and idiopathic pulmonary fibrosis.
Alimentiv, Satisfai Health, and Virgo partner to bring AI imaging technology to clinical trials in gastroenterology.